George C. Clark - 10 May 2022 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd.

Role: VP, Chief Accounting Officer
Signature: /s/ George Clark
Issuer symbol: N/A
Transactions as of: 10 May 2022
Net transactions value: -$473,340
Form type: 4
Filing time: 12 May 2022, 20:58:58 UTC
Previous filing: 24 Jan 2022
Next filing: 03 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHVN	Common Shares	Options Exercise	$120,960	+2,250	+37%	$53.76^*	8,265	10 May 2022	Direct	F1
transaction	BHVN	Common Shares	Sale	$594,300	-4,200	-51%	$141.50^*	4,065	10 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BHVN	Employee Stock Option (right to buy)	Options Exercise	$0	-2,250	-50%	$0.000000	2,250	10 May 2022	Common Shares	2,250	$53.76	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2	The shares underlying this option vest in four equal installments on December 5, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date.